Physician profile
James Moss
NPI 1902810344
$2,766.23
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,528 · 2020: $74.38 · 2021: $796 · 2022: $321 · 2023: $46.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,022.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $474.24 | 2019-2022 | |
| Shockwave Medical, INC | $220.26 | 2019-2022 | |
| Pfizer INC. | $171.55 | 2019-2022 | |
| Penumbra, INC. | $148.04 | 2021 | |
| Medtronic, INC. | $134.26 | 2021 | |
| Amgen INC. | $115.94 | 2019-2021 | |
| Boston Scientific Corporation | $97.75 | 2022-2023 | Opticross, Avvigo Guidance System |
| Janssen Pharmaceuticals, INC | $60.87 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $59.20 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $54.77 | 2019 | |
| Merck Sharp & Dohme LLC | $37.51 | 2021 | |
| Abiomed | $34.15 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $27.29 | 2019-2022 | |
| Esperion Therapeutics, INC. | $24.43 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.03 | 2021 | |
| Silk Road Medical, INC. | $19.75 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.93 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.89 | 2019 | |
| Cardiovascular Systems INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.